BCAX Stock Price Prediction 2026
Bicara Therapeutics Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- TTM Squeeze ON for 12 days - volatility compression
- MACD converging near zero line - potential energy building
- Volume showing accumulation (CMF: 0.1942)
- Recent pattern: Doji - Indecision pattern
- Price near support at $16.39
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 46.6% upside potential.
Volume Trend: Accumulation
Institutional Buying Detected - Smart money is accumulating shares
Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $17.92 | +6.7% |
| 90 Days | $20.29 | +20.8% |
| 6 Months | $23.79 | +41.6% |
| 1 Year | $30.78 | +83.2% |
More BCAX Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results